These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32845521)

  • 1. Databases for the targeted COVID-19 therapeutics.
    Wang Y; Li F; Zhang Y; Zhou Y; Tan Y; Chen Y; Zhu F
    Br J Pharmacol; 2020 Nov; 177(21):4999-5001. PubMed ID: 32845521
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung tissue distribution of drugs as a key factor for COVID-19 treatment.
    Wang Y; Chen L
    Br J Pharmacol; 2020 Nov; 177(21):4995-4996. PubMed ID: 32424836
    [No Abstract]   [Full Text] [Related]  

  • 3. Boosting the arsenal against COVID-19 through computational drug repurposing.
    Ciliberto G; Cardone L
    Drug Discov Today; 2020 Jun; 25(6):946-948. PubMed ID: 32304645
    [No Abstract]   [Full Text] [Related]  

  • 4. East meets West in COVID-19 therapeutics.
    Wang S; Zeng X; Wang Y; Zhao Y; Chen W; Chen YZ
    Pharmacol Res; 2020 Sep; 159():105008. PubMed ID: 32531323
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
    Taccone FS; Gorham J; Vincent JL
    Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential role of nanomedicine on COVID-19 therapeutics.
    Mainardes RM; Diedrich C
    Ther Deliv; 2020 Jul; 11(7):411-414. PubMed ID: 32594863
    [No Abstract]   [Full Text] [Related]  

  • 8. Fight against novel coronavirus: A perspective of medicinal chemists.
    Amin SA; Jha T
    Eur J Med Chem; 2020 Sep; 201():112559. PubMed ID: 32563814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BET 2: Hydroxychloroquine in the treatment of COVID-19.
    Howard L; Baombe J; Reynard C
    Emerg Med J; 2020 Jul; 37(7):451-453. PubMed ID: 32616659
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.
    Fassihi SC; Nabar NR; Fassihi R
    Br J Pharmacol; 2020 Nov; 177(21):4997-4998. PubMed ID: 32562278
    [No Abstract]   [Full Text] [Related]  

  • 11. Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
    Severa M; Farina C; Salvetti M; Coccia EM
    Front Immunol; 2020; 11():1459. PubMed ID: 32655578
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19: A Defining Moment for Clinical Pharmacology?
    van der Graaf PH; Giacomini KM
    Clin Pharmacol Ther; 2020 Jul; 108(1):11-15. PubMed ID: 32350861
    [No Abstract]   [Full Text] [Related]  

  • 13. Discovering small-molecule therapeutics against SARS-CoV-2.
    Tiwari V; Beer JC; Sankaranarayanan NV; Swanson-Mungerson M; Desai UR
    Drug Discov Today; 2020 Aug; 25(8):1535-1544. PubMed ID: 32574699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combating devastating COVID-19 by drug repurposing.
    Pawar AY
    Int J Antimicrob Agents; 2020 Aug; 56(2):105984. PubMed ID: 32305589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: molecular targets, drug repurposing and new avenues for drug discovery.
    Senger MR; Evangelista TCS; Dantas RF; Santana MVDS; Gonçalves LCS; de Souza Neto LR; Ferreira SB; Silva-Junior FP
    Mem Inst Oswaldo Cruz; 2020; 115():e200254. PubMed ID: 33027420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29.
    Alexander SPH; Armstrong JF; Davenport AP; Davies JA; Faccenda E; Harding SD; Levi-Schaffer F; Maguire JJ; Pawson AJ; Southan C; Spedding M
    Br J Pharmacol; 2020 Nov; 177(21):4942-4966. PubMed ID: 32358833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
    Martin JH; Bowden NA
    Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
    [No Abstract]   [Full Text] [Related]  

  • 18. Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2.
    Wamae CN
    Am J Trop Med Hyg; 2020 Jul; 103(1):10-11. PubMed ID: 32458795
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
    Gao J; Hu S
    Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BET 1: Lopinavir-ritonavir and COVID-19.
    Dolan D; Ingham J; Baombe J
    Emerg Med J; 2020 Jul; 37(7):450-451. PubMed ID: 32616658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.